Growth and neuroendocrine dysfunction following therapy for childhood cancer (Q41455285)

30 September 2017

1 reference

title

Growth and neuroendocrine dysfunction following therapy for childhood cancer (English)

1 reference

30 September 2017

1 reference

Sklar CA

1

1 reference

30 September 2017

1 April 1997

1 reference

Pediatric Clinics of North America

30 September 2017

1 reference

30 September 2017

44

1 reference

30 September 2017

2

1 reference

30 September 2017

489-503

1 reference

Endocrine sequelae of antineoplastic therapy in childhood head and neck malignancies

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

A prospective study of the development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Dose dependency of time of onset of radiation-induced growth hormone deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Growth in children treated for acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Growth response to growth hormone therapy following craniospinal irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Growth response to growth hormone therapy following cranial irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Hypothalamic-pituitary dysfunction after radiation for brain tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Disproportionate short stature after cranial irradiation and combination chemotherapy for leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Serial thyroid function measurements in children with Hodgkin disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Pubertal growth in young adult survivors of childhood leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Dose, time and fractionation: A clinical hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Risk of leukemia after treatment with pituitary growth hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Thyroid Diseases after Treatment of Hodgkin's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Prolonged intrathecal chemotherapy replacing cranial irradiation in high-risk acute lymphatic leukaemia: long-term follow up with cerebral computed tomography scans and endocrinological studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Risk factors for thyroid abnormalities after neck irradiation for childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Final attained height in patients successfully treated for childhood acute lymphoblastic leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Thyroid dysfunction after radiotherapy and chemotherapy of brain tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

High-dose methotrexate causes short-term suppression of growth in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Is brain tumor recurrence increased following growth hormone treatment?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Hypothalamic-pituitary-adrenal function following cranial irradiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Age at onset of puberty following high-dose central nervous system radiation therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Endocrine deficit after fractionated total body irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Cranial irradiation and early puberty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Growth hormone and tumour recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Growth and puberty after growth hormone treatment after irradiation for brain tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

The effects of adjuvant chemotherapy on growth in children with medulloblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Growth and final height after treatment for childhood Hodgkin disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Growth and endocrine disorders secondary to cranial irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Chemotherapy-induced growth hormone deficiency in children with cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Combined treatment with growth hormone and gonadotropin-releasing hormone analogues in children with isolated growth hormone deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Irradiation-induced growth failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Effect of spinal irradiation on growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Stature loss following skeletal irradiation for childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Efficacy of insulin-like growth factor binding protein 3 in predicting the growth hormone response to provocative testing in children treated with cranial irradiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Growth following therapy for childhood cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Chronic neuroendocrinological sequelae of radiation therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Thyroid dysfunction among long-term survivors of bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Leukemia in Growth-Hormone Treated Patients: An Update, 1992

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Growth and growth hormone secretion after treatment for acute lymphoblastic leukemia in childhood. 18-Gy versus 24-Gy cranial irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Response to growth hormone treatment and final height after cranial or craniospinal irradiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Growth following single fraction and fractionated total body irradiation for bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Impaired pubertal growth in acute lymphoblastic leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Effect of abdominal irradiation on growth in boys treated for a wilms′ tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Radiation induced height impairment in pediatric Hodgkin's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

Biologic basis for altered fractionation schemes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0031-3955%2805%2970487-9

10.1016/S0031-3955(05)70487-9

7 January 2021

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9130931